Definitive Contract 75F40125C00009

Award Date 1/15/25
Potential Completion Date 1/14/26
Potential Value $496K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Boston, MA 02114, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $811,126.00, was issued by the U.S. Food and Drug Administration (FDA) to Digital Medicine Society Inc., a non-profit organization based in Boston, Massachusetts. The contract was awarded under a Broad Agency Announcement (BAA) solicitation for research and development to support the FDA's regulatory science and innovation mission. The contract is a Definitive Contract with a Firm Fixed Price pricing type, and has an ultimate completion date of December 31,...
<p>This is a $359,880.23 firm fixed price definitive contract awarded by the Food and Drug Administration (FDA), a civilian agency, to US Data Management, LLC for a pilot project to support the implementation of the Drug Supply Chain Security Act. The contract does not have a set-aside designation. The contract's ultimate completion date is September 15, 2020. No other details about major subcontractors or the agency's broader programs are provided in the information given.</p>
This contract was awarded by the Department of Health and Human Services Food and Drug Administration (HHS FDA) to Digital Infuzion, Inc., a minority-owned, for-profit Subchapter S corporation that provides software and healthcare IT services. The contract, valued at $730,303.96, was awarded under a Broad Agency Announcement (BAA) entitled &quot;Integrating EHR RWD for FDA Regulated Submission and Clinical Research.&quot; The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing...
The Department of Health and Human Services Food and Drug Administration awarded a $84,490.00 firm fixed price purchase order contract to the Clinical Data Interchange Standards Consortium Inc. (Cdisc), a non-profit organization. The contract is for CDISC membership services, including Cdisc training, support for clinical research data standards and technical resources, and activities supporting common data model harmonization and FHIR to generate clinical evidence from real-world data for...
The Department of Health and Human Services Food and Drug Administration awarded a $329,470 firm fixed price purchase order to Digim Solution LLC for image processing, modeling and simulation software. The solicitation sought a platform capable of image analysis, data management, computing resource management, quantitative data extraction, predictive simulation, and FDA 21 CFR Part 11 compliance to assess product quality attributes. Performance will take place in Woburn, Massachusetts through...
This is a $709,554 firm fixed price definitive contract awarded by the Food and Drug Administration (FDA) to Digim Solution LLC, a minority-owned small business. The contract is for correlative 3D imaging and AI analysis to establish critical performance attributes of polymeric microsphere products in support of performance evaluation. This work was originally solicited through an FDA Broad Agency Announcement that sought research and development proposals to advance regulatory science across...
The federal contract award was issued by the Food and Drug Administration (FDA), a civilian agency, to DRT Strategies, Inc., a minority-owned, woman-owned small business. The contract, valued at $942,163.80, is for Office of Computational Science Program and Project Management and Coordination Support. This is a Delivery Order contract with a labor hours pricing type. The contract has no set-aside designation and supports the FDA's mission through IT program and project management, data...
This federal contract award, valued at $393,043.00, was issued by the U.S. Food and Drug Administration (FDA) to Medstar Health Research Institute Inc., doing business as Medstar Research Institute, a non-profit healthcare organization. The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type and supports &quot;STRENGTHENING SOCIAL AND BEHAVIORAL SCIENCE AT FDA BY ENHANCING AUDIENCE UNDERSTANDING.&quot; No set-aside designation was used for this contract. The original...
This federal contract award, valued at $399,824.04, was issued to International Business Machines Corporation (IBM) by the Food and Drug Administration (FDA) to develop digital health technologies (DHT) biostatistics training materials. The contract is a Blanket Purchase Agreement (BPA) call under the Regulatory Review Support Services vehicle. This is not a set-aside contract. IBM, a major IT services provider to the federal government, will be the prime contractor on this project. Callideo,...
This federal contract award, valued at $15,000.00, was issued by the Food and Drug Administration (FDA) to the Clinical Data Interchange Standards Consortium Inc. (CDISC), a non-profit organization that specializes in developing data standards for the healthcare and life sciences industry. The contract is for CDISC membership services and does not have a set-aside designation. CDISC has been awarded multiple federal contracts and grants from the FDA and National Cancer Institute, primarily...

This federal contract award, valued at $496,171, was issued by the U.S. Food and Drug Administration (FDA) to Digital Medicine Society Inc., a non-profit organization based in Boston, Massachusetts. The contract is for expanding patient-generated health data training, which supports the FDA's Center for Devices and Radiological Health's (CDRH) need to enhance its capabilities in this area. The contract is structured as a Definitive Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. This award is one of three notable federal contracts Digital Medicine Society Inc. has secured over the past two years, demonstrating the organization's expertise in developing research tools, evaluation frameworks, and supporting regulatory science initiatives related to digital health technologies.

Generated 5/22/25, 8:10 PM